BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15500010)

  • 1. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
    Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
    J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
    Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
    Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer.
    Oshita F; Sekiyama A; Ito H; Kameda Y; Miyagi Y
    Oncol Rep; 2006 Oct; 16(4):817-21. PubMed ID: 16969500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.
    Taniwaki M; Daigo Y; Ishikawa N; Takano A; Tsunoda T; Yasui W; Inai K; Kohno N; Nakamura Y
    Int J Oncol; 2006 Sep; 29(3):567-75. PubMed ID: 16865272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DDP-sensitivity-related genes in 10 lung cancer cell lines].
    Li CH; Cai L; Chen XS; Meng QW; Sui GJ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):418-21. PubMed ID: 19024514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
    Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
    Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical role of MDR1 gene expression in human lung cancer.
    Oka M; Fukuda M; Sakamoto A; Takatani H; Fukuda M; Soda H; Kohno S
    Anticancer Res; 1997; 17(1B):721-4. PubMed ID: 9066608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T; Chyczewska E; Naumnik W; Talalaj J; Panek B; Ossolinska M
    Exp Oncol; 2004 Dec; 26(4):316-9. PubMed ID: 15627066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
    Sève P; Isaac S; Trédan O; Souquet PJ; Pachéco Y; Pérol M; Lafanéchère L; Penet A; Peiller EL; Dumontet C
    Clin Cancer Res; 2005 Aug; 11(15):5481-6. PubMed ID: 16061864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer.
    Petty RD; Kerr KM; Murray GI; Nicolson MC; Rooney PH; Bissett D; Collie-Duguid ES
    J Clin Oncol; 2006 Apr; 24(11):1729-44. PubMed ID: 16549823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
    Vogt U; Zaczek A; Klinke F; Granetzny A; Bielawski K; Falkiewicz B
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):141-7. PubMed ID: 11935300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
    Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas.
    Nakamura H; Saji H; Ogata A; Hosaka M; Hagiwara M; Saijo T; Kawasaki N; Kato H
    Cancer; 2003 Jun; 97(11):2798-805. PubMed ID: 12767093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.